Incidence of Post-Transplantation Lymphoproliferative Disease in Andalusia (1990–2009)
Abstract Background Post-transplantation lymphoproliferative disease (PTLD) is a severe complication of renal transplantation (RT) but information about its incidence and predisposing factors is diverse, varying according to geographic area and study period. Methods We analyzed the incidence of PTLD...
Gespeichert in:
Veröffentlicht in: | Transplantation proceedings 2013-12, Vol.45 (10), p.3592-3594 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3594 |
---|---|
container_issue | 10 |
container_start_page | 3592 |
container_title | Transplantation proceedings |
container_volume | 45 |
creator | Govantes, M.A. Gentil Esteve, A. Franco Ramos, M. Toro Gracia De Guindo, M.C Sánchez, L. Fuentes Blanca, M.A. Mazuecos Rodríguez-Benot, A Blandino, M. Vidal De la Nuez, P. Castro Rodríguez, D. Burgos |
description | Abstract Background Post-transplantation lymphoproliferative disease (PTLD) is a severe complication of renal transplantation (RT) but information about its incidence and predisposing factors is diverse, varying according to geographic area and study period. Methods We analyzed the incidence of PTLD after all RT performed at adult transplantation centers in Andalusia from January 1, 1990 to December 31, 2009, recorded in the Andalusian Transplant Co-ordination Information System (SICATA) regional computerized database (n = 5577). We calculated the risk of PTLD using the Kaplan-Meier curve, censoring for organ failure and incidence rate per patient-year of exposure. Log-rank comparisons were made by center (n = 5), decade (1990–1999 vs 2000–2009), age group, recipient gender, hepatitis C virus (HCV) serology, transplantation number, and duration of pre-RT replacement therapy (per quartiles). Results We identified 60 cases of PTLD. The pre-RT treatment time was 48.2 ± 60 months; 11.7% were retransplantations, and 10.4% had a positive HCV serology. The median post-RT time before diagnosis of PTLD was 5.98 years. At the time of the database analysis, only 11 patients (18%) were alive with a functioning transplant; 10% had returned to dialysis and 72% had died. The actuarial incidence of PTLD at 1, 5, 10, and 20 years post-RT was 0.2%, 0.5%, 1.6%, and 2.9%, respectively; the exposure rate was 14.71 PTLD/10,000 patient-years (95% confidence interval [CI], 12.3–17.1). Although the incidence tended to be higher in 1990–1999 than 2000–2009 (16.8 vs 12.1 cases/10,000 patient-years), in the actuarial study the difference was far from significant (at 7.5 years, 1.2 vs 0.8%; P = .4). Nor were there significant differences in the curves of incidence per RT center (1%–1.2% of patients) or recipient characteristics. Conclusions The cumulative incidence of PTLD in Andalusia in patients with a functioning kidney transplant during 1990–2009 was 2.9% at 20 years. There was no significant variation between the RT centers or over time. No associated factors were identified among the basic recipient variables studied. |
doi_str_mv | 10.1016/j.transproceed.2013.10.030 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1466373737</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041134513010518</els_id><sourcerecordid>1466373737</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-474f0421fb2cf981357f09a09afd9ad9b482db3a07c64a086b26705b4f63c7e13</originalsourceid><addsrcrecordid>eNqNkd1qFDEUx4NY7Lr6CjJ4VS9me_IxmRkvhNLaWlhQsIJ3IZM5wayzyZrMFPbOd_ANfZJmui2IVyUhh-T8z0d-h5C3FFYUqDzdrMaofdrFYBD7FQPKs2MFHJ6RBW1qXjLJ-HOyABC0pFxUx-RlShvIdyb4C3KcTypa2SzI92tvXI_eYBFs8SWksby5Tz5oP-rRBV-s99vdj5CrDc5izG-3WFy4hDph4Xxx5ns9TMnp4oS2Lfz9_YcBtO9ekSOrh4SvH-ySfLv8eHP-qVx_vro-P1uXRvBqLEUtbO6K2o4Z2zaUV7WFVudt-1b3bSca1ndcQ22k0NDIjskaqk5YyU2NlC_JySFvbvDXhGlUW5cMDrl_DFNSVEjJ6_u1JO8PUhNDShGt2kW31XGvKKiZrNqof8mqmezsy2Rz8JuHOlO3zb7H0EeUWXBxEGD-7a3DqJJxM9jeRTSj6oN7Wp0P_6Uxg_PO6OEn7jFtwhR95qmoSkyB-jrPeB4x5UChog2_A5BXpYI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1466373737</pqid></control><display><type>article</type><title>Incidence of Post-Transplantation Lymphoproliferative Disease in Andalusia (1990–2009)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Govantes, M.A. Gentil ; Esteve, A. Franco ; Ramos, M. Toro ; Gracia De Guindo, M.C ; Sánchez, L. Fuentes ; Blanca, M.A. Mazuecos ; Rodríguez-Benot, A ; Blandino, M. Vidal ; De la Nuez, P. Castro ; Rodríguez, D. Burgos</creator><creatorcontrib>Govantes, M.A. Gentil ; Esteve, A. Franco ; Ramos, M. Toro ; Gracia De Guindo, M.C ; Sánchez, L. Fuentes ; Blanca, M.A. Mazuecos ; Rodríguez-Benot, A ; Blandino, M. Vidal ; De la Nuez, P. Castro ; Rodríguez, D. Burgos</creatorcontrib><description>Abstract Background Post-transplantation lymphoproliferative disease (PTLD) is a severe complication of renal transplantation (RT) but information about its incidence and predisposing factors is diverse, varying according to geographic area and study period. Methods We analyzed the incidence of PTLD after all RT performed at adult transplantation centers in Andalusia from January 1, 1990 to December 31, 2009, recorded in the Andalusian Transplant Co-ordination Information System (SICATA) regional computerized database (n = 5577). We calculated the risk of PTLD using the Kaplan-Meier curve, censoring for organ failure and incidence rate per patient-year of exposure. Log-rank comparisons were made by center (n = 5), decade (1990–1999 vs 2000–2009), age group, recipient gender, hepatitis C virus (HCV) serology, transplantation number, and duration of pre-RT replacement therapy (per quartiles). Results We identified 60 cases of PTLD. The pre-RT treatment time was 48.2 ± 60 months; 11.7% were retransplantations, and 10.4% had a positive HCV serology. The median post-RT time before diagnosis of PTLD was 5.98 years. At the time of the database analysis, only 11 patients (18%) were alive with a functioning transplant; 10% had returned to dialysis and 72% had died. The actuarial incidence of PTLD at 1, 5, 10, and 20 years post-RT was 0.2%, 0.5%, 1.6%, and 2.9%, respectively; the exposure rate was 14.71 PTLD/10,000 patient-years (95% confidence interval [CI], 12.3–17.1). Although the incidence tended to be higher in 1990–1999 than 2000–2009 (16.8 vs 12.1 cases/10,000 patient-years), in the actuarial study the difference was far from significant (at 7.5 years, 1.2 vs 0.8%; P = .4). Nor were there significant differences in the curves of incidence per RT center (1%–1.2% of patients) or recipient characteristics. Conclusions The cumulative incidence of PTLD in Andalusia in patients with a functioning kidney transplant during 1990–2009 was 2.9% at 20 years. There was no significant variation between the RT centers or over time. No associated factors were identified among the basic recipient variables studied.</description><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/j.transproceed.2013.10.030</identifier><identifier>PMID: 24314968</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Female ; Humans ; Incidence ; Kaplan-Meier Estimate ; Kidney Transplantation - adverse effects ; Kidney Transplantation - mortality ; Lymphoproliferative Disorders - epidemiology ; Lymphoproliferative Disorders - mortality ; Male ; Middle Aged ; Registries ; Retrospective Studies ; Risk Factors ; Spain - epidemiology ; Surgery ; Time Factors ; Treatment Outcome</subject><ispartof>Transplantation proceedings, 2013-12, Vol.45 (10), p.3592-3594</ispartof><rights>Elsevier Inc.</rights><rights>2013 Elsevier Inc.</rights><rights>Copyright © 2013 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-474f0421fb2cf981357f09a09afd9ad9b482db3a07c64a086b26705b4f63c7e13</citedby><cites>FETCH-LOGICAL-c435t-474f0421fb2cf981357f09a09afd9ad9b482db3a07c64a086b26705b4f63c7e13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.transproceed.2013.10.030$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24314968$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Govantes, M.A. Gentil</creatorcontrib><creatorcontrib>Esteve, A. Franco</creatorcontrib><creatorcontrib>Ramos, M. Toro</creatorcontrib><creatorcontrib>Gracia De Guindo, M.C</creatorcontrib><creatorcontrib>Sánchez, L. Fuentes</creatorcontrib><creatorcontrib>Blanca, M.A. Mazuecos</creatorcontrib><creatorcontrib>Rodríguez-Benot, A</creatorcontrib><creatorcontrib>Blandino, M. Vidal</creatorcontrib><creatorcontrib>De la Nuez, P. Castro</creatorcontrib><creatorcontrib>Rodríguez, D. Burgos</creatorcontrib><title>Incidence of Post-Transplantation Lymphoproliferative Disease in Andalusia (1990–2009)</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><description>Abstract Background Post-transplantation lymphoproliferative disease (PTLD) is a severe complication of renal transplantation (RT) but information about its incidence and predisposing factors is diverse, varying according to geographic area and study period. Methods We analyzed the incidence of PTLD after all RT performed at adult transplantation centers in Andalusia from January 1, 1990 to December 31, 2009, recorded in the Andalusian Transplant Co-ordination Information System (SICATA) regional computerized database (n = 5577). We calculated the risk of PTLD using the Kaplan-Meier curve, censoring for organ failure and incidence rate per patient-year of exposure. Log-rank comparisons were made by center (n = 5), decade (1990–1999 vs 2000–2009), age group, recipient gender, hepatitis C virus (HCV) serology, transplantation number, and duration of pre-RT replacement therapy (per quartiles). Results We identified 60 cases of PTLD. The pre-RT treatment time was 48.2 ± 60 months; 11.7% were retransplantations, and 10.4% had a positive HCV serology. The median post-RT time before diagnosis of PTLD was 5.98 years. At the time of the database analysis, only 11 patients (18%) were alive with a functioning transplant; 10% had returned to dialysis and 72% had died. The actuarial incidence of PTLD at 1, 5, 10, and 20 years post-RT was 0.2%, 0.5%, 1.6%, and 2.9%, respectively; the exposure rate was 14.71 PTLD/10,000 patient-years (95% confidence interval [CI], 12.3–17.1). Although the incidence tended to be higher in 1990–1999 than 2000–2009 (16.8 vs 12.1 cases/10,000 patient-years), in the actuarial study the difference was far from significant (at 7.5 years, 1.2 vs 0.8%; P = .4). Nor were there significant differences in the curves of incidence per RT center (1%–1.2% of patients) or recipient characteristics. Conclusions The cumulative incidence of PTLD in Andalusia in patients with a functioning kidney transplant during 1990–2009 was 2.9% at 20 years. There was no significant variation between the RT centers or over time. No associated factors were identified among the basic recipient variables studied.</description><subject>Adult</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>Kaplan-Meier Estimate</subject><subject>Kidney Transplantation - adverse effects</subject><subject>Kidney Transplantation - mortality</subject><subject>Lymphoproliferative Disorders - epidemiology</subject><subject>Lymphoproliferative Disorders - mortality</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Registries</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Spain - epidemiology</subject><subject>Surgery</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkd1qFDEUx4NY7Lr6CjJ4VS9me_IxmRkvhNLaWlhQsIJ3IZM5wayzyZrMFPbOd_ANfZJmui2IVyUhh-T8z0d-h5C3FFYUqDzdrMaofdrFYBD7FQPKs2MFHJ6RBW1qXjLJ-HOyABC0pFxUx-RlShvIdyb4C3KcTypa2SzI92tvXI_eYBFs8SWksby5Tz5oP-rRBV-s99vdj5CrDc5izG-3WFy4hDph4Xxx5ns9TMnp4oS2Lfz9_YcBtO9ekSOrh4SvH-ySfLv8eHP-qVx_vro-P1uXRvBqLEUtbO6K2o4Z2zaUV7WFVudt-1b3bSca1ndcQ22k0NDIjskaqk5YyU2NlC_JySFvbvDXhGlUW5cMDrl_DFNSVEjJ6_u1JO8PUhNDShGt2kW31XGvKKiZrNqof8mqmezsy2Rz8JuHOlO3zb7H0EeUWXBxEGD-7a3DqJJxM9jeRTSj6oN7Wp0P_6Uxg_PO6OEn7jFtwhR95qmoSkyB-jrPeB4x5UChog2_A5BXpYI</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>Govantes, M.A. Gentil</creator><creator>Esteve, A. Franco</creator><creator>Ramos, M. Toro</creator><creator>Gracia De Guindo, M.C</creator><creator>Sánchez, L. Fuentes</creator><creator>Blanca, M.A. Mazuecos</creator><creator>Rodríguez-Benot, A</creator><creator>Blandino, M. Vidal</creator><creator>De la Nuez, P. Castro</creator><creator>Rodríguez, D. Burgos</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20131201</creationdate><title>Incidence of Post-Transplantation Lymphoproliferative Disease in Andalusia (1990–2009)</title><author>Govantes, M.A. Gentil ; Esteve, A. Franco ; Ramos, M. Toro ; Gracia De Guindo, M.C ; Sánchez, L. Fuentes ; Blanca, M.A. Mazuecos ; Rodríguez-Benot, A ; Blandino, M. Vidal ; De la Nuez, P. Castro ; Rodríguez, D. Burgos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-474f0421fb2cf981357f09a09afd9ad9b482db3a07c64a086b26705b4f63c7e13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>Kaplan-Meier Estimate</topic><topic>Kidney Transplantation - adverse effects</topic><topic>Kidney Transplantation - mortality</topic><topic>Lymphoproliferative Disorders - epidemiology</topic><topic>Lymphoproliferative Disorders - mortality</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Registries</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Spain - epidemiology</topic><topic>Surgery</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Govantes, M.A. Gentil</creatorcontrib><creatorcontrib>Esteve, A. Franco</creatorcontrib><creatorcontrib>Ramos, M. Toro</creatorcontrib><creatorcontrib>Gracia De Guindo, M.C</creatorcontrib><creatorcontrib>Sánchez, L. Fuentes</creatorcontrib><creatorcontrib>Blanca, M.A. Mazuecos</creatorcontrib><creatorcontrib>Rodríguez-Benot, A</creatorcontrib><creatorcontrib>Blandino, M. Vidal</creatorcontrib><creatorcontrib>De la Nuez, P. Castro</creatorcontrib><creatorcontrib>Rodríguez, D. Burgos</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Govantes, M.A. Gentil</au><au>Esteve, A. Franco</au><au>Ramos, M. Toro</au><au>Gracia De Guindo, M.C</au><au>Sánchez, L. Fuentes</au><au>Blanca, M.A. Mazuecos</au><au>Rodríguez-Benot, A</au><au>Blandino, M. Vidal</au><au>De la Nuez, P. Castro</au><au>Rodríguez, D. Burgos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidence of Post-Transplantation Lymphoproliferative Disease in Andalusia (1990–2009)</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>45</volume><issue>10</issue><spage>3592</spage><epage>3594</epage><pages>3592-3594</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><abstract>Abstract Background Post-transplantation lymphoproliferative disease (PTLD) is a severe complication of renal transplantation (RT) but information about its incidence and predisposing factors is diverse, varying according to geographic area and study period. Methods We analyzed the incidence of PTLD after all RT performed at adult transplantation centers in Andalusia from January 1, 1990 to December 31, 2009, recorded in the Andalusian Transplant Co-ordination Information System (SICATA) regional computerized database (n = 5577). We calculated the risk of PTLD using the Kaplan-Meier curve, censoring for organ failure and incidence rate per patient-year of exposure. Log-rank comparisons were made by center (n = 5), decade (1990–1999 vs 2000–2009), age group, recipient gender, hepatitis C virus (HCV) serology, transplantation number, and duration of pre-RT replacement therapy (per quartiles). Results We identified 60 cases of PTLD. The pre-RT treatment time was 48.2 ± 60 months; 11.7% were retransplantations, and 10.4% had a positive HCV serology. The median post-RT time before diagnosis of PTLD was 5.98 years. At the time of the database analysis, only 11 patients (18%) were alive with a functioning transplant; 10% had returned to dialysis and 72% had died. The actuarial incidence of PTLD at 1, 5, 10, and 20 years post-RT was 0.2%, 0.5%, 1.6%, and 2.9%, respectively; the exposure rate was 14.71 PTLD/10,000 patient-years (95% confidence interval [CI], 12.3–17.1). Although the incidence tended to be higher in 1990–1999 than 2000–2009 (16.8 vs 12.1 cases/10,000 patient-years), in the actuarial study the difference was far from significant (at 7.5 years, 1.2 vs 0.8%; P = .4). Nor were there significant differences in the curves of incidence per RT center (1%–1.2% of patients) or recipient characteristics. Conclusions The cumulative incidence of PTLD in Andalusia in patients with a functioning kidney transplant during 1990–2009 was 2.9% at 20 years. There was no significant variation between the RT centers or over time. No associated factors were identified among the basic recipient variables studied.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24314968</pmid><doi>10.1016/j.transproceed.2013.10.030</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0041-1345 |
ispartof | Transplantation proceedings, 2013-12, Vol.45 (10), p.3592-3594 |
issn | 0041-1345 1873-2623 |
language | eng |
recordid | cdi_proquest_miscellaneous_1466373737 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Adult Female Humans Incidence Kaplan-Meier Estimate Kidney Transplantation - adverse effects Kidney Transplantation - mortality Lymphoproliferative Disorders - epidemiology Lymphoproliferative Disorders - mortality Male Middle Aged Registries Retrospective Studies Risk Factors Spain - epidemiology Surgery Time Factors Treatment Outcome |
title | Incidence of Post-Transplantation Lymphoproliferative Disease in Andalusia (1990–2009) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T02%3A33%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidence%20of%20Post-Transplantation%20Lymphoproliferative%20Disease%20in%20Andalusia%20(1990%E2%80%932009)&rft.jtitle=Transplantation%20proceedings&rft.au=Govantes,%20M.A.%20Gentil&rft.date=2013-12-01&rft.volume=45&rft.issue=10&rft.spage=3592&rft.epage=3594&rft.pages=3592-3594&rft.issn=0041-1345&rft.eissn=1873-2623&rft_id=info:doi/10.1016/j.transproceed.2013.10.030&rft_dat=%3Cproquest_cross%3E1466373737%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1466373737&rft_id=info:pmid/24314968&rft_els_id=S0041134513010518&rfr_iscdi=true |